Anti-Mullerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population

Bozdag G., Mumusoglu S., Coskun Z., Yarali H., Yildiz B.

REPRODUCTIVE BIOMEDICINE ONLINE, vol.39, no.3, pp.522-529, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 3
  • Publication Date: 2019
  • Doi Number: 10.1016/j.rbmo.2019.04.002
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.522-529
  • Keywords: Anti-Mullerian hormone, Antral follicle count, Area under the curve, Polycystic ovary morphology, Polycystic ovary syndrome, POLYCYSTIC-OVARY-SYNDROME, CARDIOMETABOLIC RISK, INHIBITING SUBSTANCE, FOLLICULAR STATUS, WOMEN, AMH, PREVALENCE, METAANALYSIS, ULTRASOUND, ESTRADIOL
  • Hacettepe University Affiliated: Yes


Research question: Is anti-Mullerian hormone (AMH) a valid tool to diagnose polycystic ovary syndrome (PCOS) according to different subsets of criteria among an unselected group of women?